TRAVOPROST Mepha Plus 0.04mg/5mg fl 2.5 ml
7680667300014
CH-66730
S01ED51
11.09.0.
Active substances:
Reimbursement limitations:
ASACOL
Proctite et Proctosigmoidite
1 / 3
google
Details
- Product number
- 6673001
- CPT
- -
- Packaging group
- 2,5
- Unit
- ml
- Composition
- travoprostum 40 µg, timololum 5 mg ut timololi maleas, benzalkonii chloridum 0.15 mg, macrogolglyceroli hydroxystearas, trometamolum, dinatrii edetas, acidum boricum, mannitolum, natrii hydroxidum, aqua purificata q.s. ad solutionem pro 1 ml.
Articles (1)
Travoprost-Mepha Plus 0.04mg/5mg, Augentropfen
Augentropfen
2,5
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
travoprostum
|
40.0 UG | Substance | Wirkstoff (Principe actif) |
|
timololum
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
timololi maleas
|
- | Substance | WIZUS |
|
benzalkonii chloridum
|
0.15 MG | Substance | HBESI |
|
macrogolglyceroli hydroxystearas
|
- | Substance | HNIDK |
|
trometamolum
|
- | Substance | HNIDK |
|
dinatrii edetas
|
- | Substance | HNIDK |
|
acidum boricum
|
- | Substance | HNIDK |
|
mannitolum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
aqua purificata
|
- | Substance | HNIDK |
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 66730
- Drug name
- Travoprost-Mepha Plus, Augentropfen
- Galenic form
- AUL
- ATC Code
- S01ED51
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 31/01/2019
- Authorization expiration date
- 01/09/2026
- IT number
- 11.09.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TRAVOPROST Mepha Plus 0.04mg/5mg fl 2.5 ml
- Description (DE)
- TRAVOPROST Mepha Plus 0.04mg/5mg Fl 2.5 ml
- Market launch
- 31/01/2019
- Market withdrawal
- 01/09/2026
- Narcotic (BTM)
- No